Insider · SEC Form 4 · Chief Executive Officer
Emily M. Leproust
Filed with the SEC as Leproust Emily M.; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: sold $94.4M of TWST. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- TWSTSold: Twist Bioscience Corp $619K
- TWSTSold: Twist Bioscience Corp $919K
- TWSTSold: Twist Bioscience Corp $8.6M
- TWSTSold: Twist Bioscience Corp $131K
- TWSTSold: Twist Bioscience Corp $923K
- TWSTSold: Twist Bioscience Corp $279K
- TWSTSold: Twist Bioscience Corp $56.3M
- TWSTSold: Twist Bioscience Corp $282K
- TWSTSold: Twist Bioscience Corp $6.3M
- TWSTSold: Twist Bioscience Corp $923K
- TWSTSold: Twist Bioscience Corp $2.5M
- TWSTSold: Twist Bioscience Corp $14.2M
- TWSTSold: Twist Bioscience Corp $435K
- TWSTSold: Twist Bioscience Corp $1.8M
- TWSTSold: Twist Bioscience Corp $147K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Other Form 4 entries
Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.
- TWST: option exercise or conversion (code M), 4 entries, Aug 10 to Sep 17, 2026
- WGS: option exercise or conversion (code M), 1 entry, Jun 18, 2026
- Code M
- An exercise or conversion of a derivative security received from the company, such as stock options.
Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.